Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

UM171 Expanded Cord Blood Transplantation Outcomes Compare Favorably to All Different Stem Cell Sources: An EBMT Registry Case-Control Analysis

Blood (2023) 142 (Supplement 1): 4977.

https://doi.org/10.1182/blood-2023-173727

Published: 2023

Journal Articles

Novel Therapeutics Targeting Acute Myeloid Leukemia (AML) Stem Cells Identified through High-Throughput Screening

Isabella Iasenza, Safia Safa, Frederic Barabe, Sonia Cellot, Brian T. Wilhelm, Kolja Eppert

Blood (2023) 142 (Supplement 1): 5011.

https://doi.org/10.1182/blood-2023-189351

Published: 2023

Journal Articles

Deciphering the Role of RAS Pathway Mutations in the Biology of Human Acute Myeloid Leukemia Using In Vivo Models

Nayeli Esparza, Eva Bresson, Safia Safa-Tahar-Henni, Joan Defrene, Élodie Roques, Florence Bonnet-Magnaval, Vincent-Philippe Lavallée, Brian T. Wilhelm, Frederic Barabe

Blood (2023) 142 (Supplement 1): 4111.

https://doi.org/10.1182/blood-2023-189877

Published: 2023

Journal Articles

Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics

Blood (2023) 142 (Supplement 1): 163.

https://doi.org/10.1182/blood-2023-186367

Published: 2023

Journal Articles

High Fatality CBFA2T3-GLIS2 Pediatric Acute Megakaryoblastic Leukemia Is Sensitive to BCL-X L Inhibition

Verena Gress, Mathieu Roussy, Sophie Cardin, Luc Boulianne, Furat Fatima, Louise Laramée, Emma R. Cheetham, Alexandre Rouette, Nehme Hachem, Véronique Lisi, Azer Farah, Melanie Bilodeau, Frederic Barabe, Vincent-Philippe Lavallée, Brian T. Wilhelm, Sonia Cellot

Blood (2022) 140 (Supplement 1): 107–108.

https://doi.org/10.1182/blood-2022-170828

Published: 2022

Journal Articles

Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study

Andree-Anne Pelland, Xavier Savard, Frederic Barabe, Vincent Laroche, Michaël Munger, Genevieve Gallagher, Nicolas Marcoux, Guy Cantin, Maxime Chénard-Poirier, Robert Delage, Marc Lalancette, Christopher Lemieux

Blood (2022) 140 (Supplement 1): 3304–3305.

https://doi.org/10.1182/blood-2022-170223

Published: 2022

Journal Articles

High-Throughput Chemical Screen on Acute Myeloid Leukemia Stem Cells Identifies Novel Anti-LSC Compounds

Isabella Angela Iasenza, Safia Safa, Frederic Barabe, Sonia Cellot, Brian T. Wilhelm, Kolja Eppert

Blood (2021) 138 (Supplement 1): 1871.

https://doi.org/10.1182/blood-2021-145369

Published: 2021

Journal Articles

UM171 Modified Cord Blood Achieves Excellent Survival and Disease Control after 2 Years of Follow-up in High and Very High Risk Malignancies

Sandra Cohen, MD FRCP(C), Jean Roy, MD, Jean-Sébastien Delisle, MD PhD, Nadia M. Bambace, MD, Imran Ahmad, MD, Silvy Lachance, MD FRCP, Léa Bernard, MD, Frederic Barabe, MD, Thomas L. Kiss, MD, Lambert Busque, MD, Denis-Claude Roy, MD, Filippo Milano, MD PhD, Guy Sauvageau, MD PhD

Blood (2019) 134 (Supplement_1): 3245.

https://doi.org/10.1182/blood-2019-121698

Published: 2019

Journal Articles

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML

Blood (2019) 134 (3): 263–276.

https://doi.org/10.1182/blood.2018862383

Published: 2019

Includes: Supplemental data

Journal Articles

Single UM171 Expanded Cord Blood Permits Transplantation of Better HLA Matched Cords with Excellent Gvhd Relapse Free Survival

Blood (2018) 132 (Supplement 1): 4658.

https://doi.org/10.1182/blood-2018-99-110188

Published: 2018

Journal Articles

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Christopher Lemieux, MD, Robert Delage, MD, Guy Cantin, MD, Frederic Barabe, MD, Vincent Laroche, MD, Rémy Angers, BSc, Genevieve Gallagher, MD

Blood (2017) 130 (Supplement 1): 5530.

https://doi.org/10.1182/blood.V130.Suppl_1.5530.5530

Published: 2017

Journal Articles

S100A9 induces differentiation of acute myeloid leukemia cells through TLR4

Malika Laouedj, Mélanie R. Tardif, Laurine Gil, Marie-Astrid Raquil, Asmaa Lachhab, Martin Pelletier, Philippe A. Tessier, Frédéric Barabé

Blood (2017) 129 (14): 1980–1990.

https://doi.org/10.1182/blood-2016-09-738005

Published: 2017

Includes: Supplemental data

Journal Articles

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo

Blood (2016) 127 (16): 2018–2027.

https://doi.org/10.1182/blood-2015-11-683649

Published: 2016

Includes: Supplemental data

Journal Articles

Myeloid-Related Protein S100A9 Induces Cellular Differentiation in Acute Myeloid Leukemia through TLR2 and TLR4 Receptors

Frédéric Barabé, MD, Malika Laouedj, Philippe Tessier

Blood (2015) 126 (23): 3858.

https://doi.org/10.1182/blood.V126.23.3858.3858

Published: 2015

Journal Articles

The Novel Leukemia Stem Cell Marker GPR56 Discriminates Leukemic Subclones with Divergent Stem Cell Properties in Human Acute Myeloid Leukemia

Caroline Pabst, MD, Anne Bergeron, PhD, Vincent-Philippe Lavallée, MD, Jonathan Yeh, PhD, Patrick Gendron, M.Sc, Jana Krosl, PhD, Geneviève Boucher, M.Sc, Sébastien Lemieux, PhD, Josee Hébert, MD, Guy Sauvageau, MD, PhD, Frédéric Barabé, MD

Blood (2015) 126 (23): 1859.

https://doi.org/10.1182/blood.V126.23.1859.1859

Published: 2015

Journal Articles

UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity

Marie-Eve Bordeleau, Romain Aucagne, Jalila Chagraoui, Simon Girard, Nadine Mayotte, Éric Bonneil, Pierre Thibault, Caroline Pabst, Anne Bergeron, Frédéric Barabé, Josée Hébert, Martin Sauvageau, Christel Boutonnet, Sylvain Meloche, Guy Sauvageau

Blood (2014) 124 (15): 2362–2369.

https://doi.org/10.1182/blood-2014-01-548651

Published: 2014

Includes: Supplemental data

Journal Articles

Effects of LMO2 on Human T-Cell Development Are Modulated by Notch Signaling

James A Kennedy, MD, PhD, Renata Teixeira, Sara Berthiaume, Frederic Barabe, MD

Blood (2011) 118 (21): 2470.

https://doi.org/10.1182/blood.V118.21.2470.2470

Published: 2011

Journal Articles

A Novel Osteoclastic Network Determines In Vitro Niche for Mouse and Human Hematopoietic Stem Cells

Eric Deneault, PhD, Brian T Wilhelm, PhD, Frederic Barabe, MD, Guy Sauvageau, MD, PhD

Blood (2011) 118 (21): 1325.

https://doi.org/10.1182/blood.V118.21.1325.1325

Published: 2011

Journal Articles

Comparing Human Fetal Liver, Cord Blood and Adult Bone Marrow Stem/Progenitor Hematopoietic Cells As Cells of Origin of Human MLL Leukemias

Sara Berthiaume, James A Kennedy, MD, PhD, Anne Bergeron, PhD, Mathieu Belanger, John E. Dick, PhD, Frederic Barabe, MD

Blood (2011) 118 (21): 2956.

https://doi.org/10.1182/blood.V118.21.2956.2956

Published: 2011

Journal Articles

DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway

Alexandra A. Lambert, Frédéric Barabé, Caroline Gilbert, Michel J. Tremblay

Blood (2011) 117 (24): 6589–6599.

https://doi.org/10.1182/blood-2011-01-331363

Published: 2011

NARROW

UM171 Expanded Cord Blood Transplantation Outcomes Compare Favorably to All Different Stem Cell Sources: An EBMT Registry Case-Control Analysis

Novel Therapeutics Targeting Acute Myeloid Leukemia (AML) Stem Cells Identified through High-Throughput Screening

Deciphering the Role of RAS Pathway Mutations in the Biology of Human Acute Myeloid Leukemia Using In Vivo Models

Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics

High Fatality CBFA2T3-GLIS2 Pediatric Acute Megakaryoblastic Leukemia Is Sensitive to BCL-X L Inhibition

Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study

High-Throughput Chemical Screen on Acute Myeloid Leukemia Stem Cells Identifies Novel Anti-LSC Compounds

UM171 Modified Cord Blood Achieves Excellent Survival and Disease Control after 2 Years of Follow-up in High and Very High Risk Malignancies

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML

Single UM171 Expanded Cord Blood Permits Transplantation of Better HLA Matched Cords with Excellent Gvhd Relapse Free Survival

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

S100A9 induces differentiation of acute myeloid leukemia cells through TLR4

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo

Myeloid-Related Protein S100A9 Induces Cellular Differentiation in Acute Myeloid Leukemia through TLR2 and TLR4 Receptors

The Novel Leukemia Stem Cell Marker GPR56 Discriminates Leukemic Subclones with Divergent Stem Cell Properties in Human Acute Myeloid Leukemia

UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity

Effects of LMO2 on Human T-Cell Development Are Modulated by Notch Signaling

A Novel Osteoclastic Network Determines In Vitro Niche for Mouse and Human Hematopoietic Stem Cells

Comparing Human Fetal Liver, Cord Blood and Adult Bone Marrow Stem/Progenitor Hematopoietic Cells As Cells of Origin of Human MLL Leukemias

DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only